Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency ...

VY1706, an IV-delivered tau silencing gene therapy that has shown up to 73% knockdown of tau mRNA in non-human primates following a single IV dose and is advancing towards IND in 2026.

Amino acids play a fundamental role in regulating how cells respond to drugs. These molecules, which form proteins, act like ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, July 30th at 11:30 ...